Free Newsletter
Stem cells used to create new trachea
In a groundbreaking development, scientists have taken a donated organ, stripped its cells and used it as a scaffold to create a new trachea from the patient's stem cells. Doctors subsequently transplanted the organ in a young woman whose windpipe had been destroyed by tuberculosis. And because the transplant relied on the patient's stem cells, no powerful immune-suppressing drugs were needed to prevent a rejection.
The Lancet described how a team of doctors from three countries collaborated on the breakthrough procedure.
"We think this represents a milestone and hope it will unlock the door for a safe and recipient-tailored transplantation of the airway in adults and children," the authors write. "We hope that these future patients will no longer suffer the trauma of speech loss, severe shortness of breath and limited social activities."
Even more importantly, the procedure helps establish hard proof that new organs can be developed from a patient's stem cells. And that points to a revolutionary new approach to developing replacement body parts. "In 20 years, this will be the most common form of surgery," says Bristol University's Professor Martin Birchall.
- read the article in The Guardian
Related Articles:
Scientists forecasts use of stem cells to grow parts
Scientists grow new heart valves from stem cells
Stem cell researchers create tiny livers
Tissue regeneration a success with new heart
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: